Sublingual Microcirculation in Children with Compensated T1D Using the SDF Method

October 16, 2024 updated by: Vlasta Krausová

Evaluation of Sublingual Microcirculation Using Sidestream Dark-Field Imaging in Children with Type 1 Diabetes Mellitus with Favorable Treatment Outcomes.

The main goal of the study is to describe the sublingual microcirculation of children with type 1 diabetes mellitus (T1D) with stable and satisfactory treatment of the disease and to compare it with previously measured parameters of healthy children, NCT05324228.

Study Overview

Status

Completed

Conditions

Detailed Description

After recording the basic anthropometric parameters, pressure and pulse, each child who meets the inclusion criteria will have their microcirculation measured using a Sidestream Dark-Field (SDF) probe placed sublingually by one examiner using the SDF method. The measurement will be performed in supine position in a disease-free period, with normal diets, at least 2 hours after the last meal, for girls outside the menses period. Premedication or analgesia will not be used. A total of 3 video clips will be recorded from different parts of the sublingual area with a minimum length of 20 seconds in a row, unless the child needs a short break between measurements. The recorded videos will then be processed offline by one evaluator who is trained and experienced in microcirculation evaluation, three best and most stable parts of each video clip will be analysed.

Study Type

Observational

Enrollment (Actual)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ústí Nad Labem, Czechia
        • Masarykova Nemocnice v Usti nad Labem, Krajska Zdravotni a.s.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The study will include 40 children with T1D. Of these, 10 pre-school children (3-5.9 years), 10 younger school children (6-10.9 years), 10 children in puberty(11-14.9 years) and 10 post-puberty adolescents will be included (15-18.9 years).

Description

Inclusion Criteria:

  • type 1 diabetes mellitus
  • informed consent of parents

Exclusion Criteria:

  • acute infection
  • period of metabolic decompensation and 14 days after it

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Children of younger school age
10 children of younger school age aged 6-10,9 years with T1D.
Children in puberty
10 children in puberty aged 11-14,9 years with T1D
Postpubertal adolescents
10 postpubertal adolescents aged 15-18,9 years with T1D

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Determination of Total Vascular Density of sublingual microcirculation of children with T1D
Time Frame: baseline
Total length of vessels divided by total surface of area
baseline
Determination of Microvascular Flow Index (MFI) of sublingual microcirculation of children with T1D
Time Frame: baseline
The image is divided into four quadrants and the predominant type of flow (absent = 0, intermittent = 1, sluggish = 2, normal = 3, and hyperdynamic = 4) is assessed in each quadrant. The MFI score represents the averaged values of the four. A 20 μm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules).
baseline
Determination of Small Vessel Density of sublingual microcirculation of children with T1D
Time Frame: baseline
Total length of small vessels divided by total surface of area. A 20 μm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules).
baseline
Determination of Proportion of Perfused Vessels (all) of sublingual microcirculation of children with T1D
Time Frame: baselina
The proportion of perfused vessels (PPV [%]) can be calculated as follows: 100 × (total number of vessels - [no flow + intermittent flow])/total number of vessels.
baselina
Determination of Proportion of Perfused Small Vessels (PPSV) of sublingual microcirculation of children with T1D
Time Frame: baseline

The proportion of perfused small vessels (PPSV [%]) can be calculated as follows: 100 × (total number of small vessels - [no flow + intermittent flow])/total number of small vessels.

A 20 μm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules).

baseline
Determination of Perfused Vessel Density (PVD) of sublingual microcirculation of children with T1D
Time Frame: baseline
Total length of vessels - (no flow + intermittent flow) divided by total surface of area
baseline
Determination of Perfused Small Vessel Density (PSVD) of sublingual microcirculation of children with T1D
Time Frame: baseline
Total length of small vessels - (small vessels with no flow + intermittent flow) divided by total surface of area. A 20 μm cut-off is used to separate small vessels (mostly capillaries) from large vessels (mostly venules).
baseline
Determination of DeBacker Score of sublingual microcirculation of children
Time Frame: baseline
In this score, three equidistant horizontal and three equidistant vertical lines are drawn on the screen. Vessel density can be calculated as the number of vessels crossing the lines divided by the total length of the lines. Higher number means better microcirculation.
baseline

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Correlation of Total Vascular Density of sublingual microcirculation with parameters of diabetic compenzation
Time Frame: baseline
Comparison of parametes in children with good and bad compenzation of T1D
baseline
Correlation of Microvascular Flow Index (MFI) of sublingual microcirculation with parameters of diabetic compenzation
Time Frame: baseline
Comparison of parametes in children with good and bad compenzation of T1D
baseline
Correlation of Small Vessel Density of sublingual microcirculation with parameters of diabetic compenzation
Time Frame: baseline
Comparison of parametes in children with good and bad compenzation of T1D
baseline
Correlation of Proportion of Perfused Vessels (all) of sublingual microcirculation with parameters of diabetic compenzation
Time Frame: baseline
Comparison of parametes in children with good and bad compenzation of T1D
baseline
Correlation of Proportion of Perfused Small Vessels (PPSV) of sublingual microcirculation with parameters of diabetic compenzation
Time Frame: baseline
Comparison of parametes in children with good and bad compenzation of T1D
baseline
Correlation of Perfused Vessel Density (PVD) of sublingual microcirculation with parameters of diabetic compenzation
Time Frame: baseline
Comparison of parametes in children with good and bad compenzation of T1D
baseline
Correlation of Perfused Small Vessel Density (PSVD) of sublingual microcirculation with parameters of diabetic compenzation
Time Frame: baseline
Comparison of parametes in children with good and bad compenzation of T1D
baseline
Correlation of DeBacker Score of sublingual microcirculation with parameters of diabetic compenzation
Time Frame: baseline
Comparison of parametes in children with good and bad compenzation of T1D
baseline
Differences of Total Vascular Density of sublingual microcirculation with parameters of healthy children in the same age categories
Time Frame: baseline
Total Vascular Density of sublingual microcirculation of healthy children has been obtained previously within study NCT05324228
baseline
Differences of Microvascular Flow Index (MFI) of sublingual microcirculation with parameters of healthy children in the same age categories
Time Frame: baseline
Microvascular Flow Index (MFI) of sublingual microcirculation of healthy children has been obtained previously within study NCT05324228
baseline
Differences of Small Vessel Density of sublingual microcirculation with parameters of healthy children in the same age categories
Time Frame: baseline
Small Vessel Density of sublingual microcirculation of healthy children has been obtained previously within study NCT05324228
baseline
Differences of Proportion of Perfused Vessels (all) of sublingual microcirculation with parameters of healthy children in the same age categories
Time Frame: baseline
Proportion of Perfused Vessels (all) of sublingual microcirculation of healthy children has been obtained previously within study NCT05324228
baseline
Differences of Proportion of Perfused Small Vessels (PPSV) of sublingual microcirculation with parameters of healthy children in the same age categories
Time Frame: baseline
Proportion of Perfused Small Vessels (PPSV) of sublingual microcirculation of healthy children has been obtained previously within study NCT05324228
baseline
Differences of Perfused Vessel Density (PVD) of sublingual microcirculation with parameters of healthy children in the same age categories
Time Frame: baseline
Perfused Vessel Density (PVD) of sublingual microcirculation of healthy children has been obtained previously within study NCT05324228
baseline
Differences of Perfused Small Vessel Density (PSVD) of sublingual microcirculation with parameters of healthy children in the same age categories
Time Frame: baseline
Perfused Small Vessel Density (PSVD) of sublingual microcirculation of healthy children has been obtained previously within study NCT05324228
baseline
Differences of DeBacker Score of sublingual microcirculation with parameters of healthy children in the same age categories
Time Frame: baseline
DeBacker Score of sublingual microcirculation of healthy children has been obtained previously within study NCT05324228
baseline
Differences in Total Vascular Density of sublingual microcirculation in different age and gender categories in children with T1D
Time Frame: baseline
Comparison in children aged 6-10,9; 11-14,9; and 15-18,9 years and males vs. females.
baseline
Differences in Microvascular Flow Index (MFI) of sublingual microcirculation in different age and gender categories in children with T1D
Time Frame: baseline
Comparison in children aged 6-10,9; 11-14,9; and 15-18,9 years and males vs. females.
baseline
Differences in Small Vessel Density of sublingual microcirculation in different age and gender categories in children with T1D
Time Frame: baseline
Comparison in children aged 6-10,9; 11-14,9; and 15-18,9 years and males vs. females.
baseline
Differences Proportion of Perfused Vessels (all) of sublingual microcirculation in different age and gender categories in children with T1D
Time Frame: baseline
Comparison in children aged 6-10,9; 11-14,9; and 15-18,9 years and males vs. females.
baseline
Differences in Proportion of Perfused Small Vessels (PPSV) of sublingual microcirculation in different age and gender categories in children with T1D
Time Frame: baseline
Comparison in children aged 6-10,9; 11-14,9; and 15-18,9 years and males vs. females.
baseline
Differences in Perfused Vessel Density (PVD) of sublingual microcirculation in different age and gender categories in children with T1D
Time Frame: baseline
Comparison in children aged 6-10,9; 11-14,9; and 15-18,9 years and males vs. females.
baseline
Differences in Perfused Small Vessel Density (PSVD) of sublingual microcirculation in different age and gender categories in children with T1D
Time Frame: baseline
Comparison in children aged 6-10,9; 11-14,9; and 15-18,9 years and males vs. females.
baseline
Differences in DeBacker Score of sublingual microcirculation in different age and gender categories in children with T1D
Time Frame: baseline
Comparison in children aged 6-10,9; 11-14,9; and 15-18,9 years and males vs. females. Higher number means better microcirculation.
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: David Neumann, MD, Ph.D., Hospital in Trutnov

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2023

Primary Completion (Actual)

September 15, 2024

Study Completion (Actual)

September 15, 2024

Study Registration Dates

First Submitted

June 28, 2023

First Submitted That Met QC Criteria

July 14, 2023

First Posted (Actual)

July 24, 2023

Study Record Updates

Last Update Posted (Actual)

October 18, 2024

Last Update Submitted That Met QC Criteria

October 16, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type1diabetes

Subscribe